Cc1cc(C)c(Cn2c(C3CC(=O)N(c4ccc(F)cc4)C3)nc3ccccc32)c(C)c1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?